Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Henk Vergunst"'
Autor:
Siebren Dijkstra, Max Peters, Diederik M. Somford, Siberyn T. Nuijens, Henk Vergunst, Leonie Exterkate
Publikováno v:
Tijdschrift voor Urologie. 11:144-154
SamenvattingHet doel van deze studie was de oncologische en functionele uitkomsten van salvage cryochirurgie (sCC) te beoordelen bij lokaal recidief prostaatcarcinoom na radiotherapie (rrPCA). De studie werd uitgevoerd bij 169 patiënten. Er vond ret
Publikováno v:
BJU International. 128:46-56
Objectives To evaluate the oncological and functional outcomes of salvage cryosurgery (SCS) for radiorecurrent prostate cancer (rrPCa). Patients and methods A total of 169 consecutive patients with biopsy confirmed rrPCa were retrospectively analysed
Autor:
Maroeska M. Rovers, Inge M. van Oort, Henk Vergunst, Jelle O. Barentsz, Caroline M. A. Hoeks, G.A.H.J. Smits, Leonard P. Bokhorst, E.H.J. Hamoen, Christina A. Hulsbergen-van de Kaa, Jorg R. Oddens, J. Alfred Witjes, Diederik M. Somford
Publikováno v:
European urology focus, 5(3), 407-415. Elsevier BV
European Urology Focus, 5, 3, pp. 407-415
European Urology Focus, 5(3), 407-415. Elsevier
European Urology Focus, 5, 407-415
European Urology Focus, 5, 3, pp. 407-415
European Urology Focus, 5(3), 407-415. Elsevier
European Urology Focus, 5, 407-415
Background: Active surveillance (AS) aims to reduce overtreatment of low-risk prostate cancer (PC). Incorporating multiparametric magnetic resonance imaging (mp-MRI) and MR-guided biopsy (MRGB) in an AS protocol might contribute to more accurate iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8330e2eaa126802ee2aee654bd24b1
https://pure.amc.nl/en/publications/value-of-serial-multiparametric-magnetic-resonance-imaging-and-magnetic-resonance-imagingguided-biopsies-in-men-with-lowrisk-prostate-cancer-on-active-surveillance-after-1-yr-followup(2a388898-233e-4355-97fc-ee3589ef8399).html
https://pure.amc.nl/en/publications/value-of-serial-multiparametric-magnetic-resonance-imaging-and-magnetic-resonance-imagingguided-biopsies-in-men-with-lowrisk-prostate-cancer-on-active-surveillance-after-1-yr-followup(2a388898-233e-4355-97fc-ee3589ef8399).html
Autor:
Frank Smit, Henk Vergunst, Inge M. van Oort, Sander A. Jannink, Theo M. de Reijke, Christina A. Hulsbergen-van de Kaa, Erik B. Cornel, Rianne J. Hendriks, Hans de Jong, Ben C. Knipscheer, Gisele H. J. M. Leyten, Peter F.A. Mulders, Jack A. Schalken, Willem J. G. Melchers, Paul J.M. Kil, Siebren Dijkstra, Daphne Hessels
Publikováno v:
Tijdschrift voor Urologie, 6, 34-43
Tijdschrift voor Urologie, 6, pp. 34-43
Tijdschrift voor urologie, 6(2), 34-43. Springer Science + Business Media
Tijdschrift voor Urologie, 6, pp. 34-43
Tijdschrift voor urologie, 6(2), 34-43. Springer Science + Business Media
Om overdiagnostiek en overbehandeling te verminderen, is er dringend behoefte aan een test voor detectie van klinisch significant prostaatcarcinoom. In deze studie werd een model ontwikkeld (met behulp van geidentificeerde biomarkers HOXC6, DLX1, TDR
Publikováno v:
European Urology Supplements. 18:e870-e871
Publikováno v:
European Urology Supplements. 17:e2873-e2874
Autor:
Peep F. M. Stalmeier, Henk Vergunst, J.J. van Tol-Geerdink, E J N T van Lin, J.A. Witjes, I.M. van Oort, P.C. Weijerman, Jan Willem H. Leer
Publikováno v:
British Journal of Cancer, 108, 9, pp. 1784-9
British Journal of Cancer, 108, 1784-9
British Journal of Cancer
British Journal of Cancer, 108, 1784-9
British Journal of Cancer
Item does not contain fulltext Background:Previous studies on the effects of different prostate cancer treatments on quality of life, were confounded because patients were not comparable. This study examined treatment effects in more comparable group
Autor:
Simon Horenblas, Marco van Vulpen, Henk G. van der Poel, Igle J. de Jong, Henk Vergunst, Max Peters, Peter L. M. Vijverberg, Jan J. Battermann, Maaike R. Moman
Publikováno v:
World journal of urology, 31(2), 403-409. SPRINGER
Current salvage treatments for recurrent prostate cancer after primary radiation therapy include radical prostatectomy, cryosurgery and brachytherapy. Because toxicity and failure rates are considerable, salvage treatments are not commonly performed.
Autor:
J. Alfred Witjes, Henk Vergunst, Theo M. de Reijke, Rianne J.M. Lammers, Harm C. Arentsen, Erik B. Cornel, J. Falke, Miroslav Ravic, Raffaella Pozzi
Publikováno v:
Journal of Urology, 189, 2077-82
Journal of Urology, 189, 6, pp. 2077-82
Journal of urology, 189(6), 2077-2082. Elsevier Inc.
Journal of Urology, 189, 6, pp. 2077-82
Journal of urology, 189(6), 2077-2082. Elsevier Inc.
Item does not contain fulltext PURPOSE: Imiquimod, a toll like receptor 7 (TLR-7) agonist, is effective as a topical treatment for skin malignancies. TMX-101 is a liquid formulation of imiquimod. In this study we establish a safety profile of TMX-101
MP02-02 MULTICENTER VALIDATION STUDY OF A MOLECULAR URINE TEST TO PREDICT HIGH-GRADE PROSTATE CANCER
Autor:
Paul J.M. Kil, Frank Smit, Inge M. van Oort, Siebren Dijkstra, Theo M. de Reijke, Rianne J. Hendriks, Christina A. Hulsbergen-van de Kaa, Erik B. Cornel, Peter F.A. Mulders, Ben C. Knipscheer, Henk Vergunst, Sander A. Jannink, Hans de Jong, Daphne Hessels, Willem J. G. Melchers, Jack A. Schalken, Gisele H. J. M. Leyten
Publikováno v:
Journal of Urology. 195